secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001737287-25-000070
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allogene shareholders elect three Class I directors, approve say-on-pay, ratify auditor
--------------------------------------------------------------------------------

- Elizabeth Barrett, Arie Belldegrun, and David Chang elected as Class I directors with >131M votes for each.
- Advisory vote on NEO compensation approved: 139.9M for, 14.2M against, 3.2M abstain.
- Ratification of Ernst & Young as auditor for FY2025: 190.1M for, 414.6K against.
- All proposals passed with no broker non-votes on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000173728725000070/0001737287-25-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000173728725000070/allo-20250618.htm
  HTML page:      https://secwatch.observer/filing/0001737287-25-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer